- Report
- July 2026
- 110 Pages
Global
From €4262EUR$4,750USD£3,640GBP
- Report
- May 2026
- 130 Pages
Global
From €4351EUR$4,850USD£3,717GBP
- Report
- May 2026
- 149 Pages
Global
From €3544EUR$3,950USD£3,027GBP
- Report
- May 2026
- 152 Pages
Global
From €3544EUR$3,950USD£3,027GBP
- Report
- May 2026
- 151 Pages
Global
From €3544EUR$3,950USD£3,027GBP
- Report
- May 2026
- 154 Pages
Global
From €3544EUR$3,950USD£3,027GBP
- Report
- May 2026
- 153 Pages
Global
From €3544EUR$3,950USD£3,027GBP
- Report
- May 2026
- 148 Pages
Global
From €3544EUR$3,950USD£3,027GBP
- Report
- May 2026
- 146 Pages
Global
From €3544EUR$3,950USD£3,027GBP
- Report
- May 2026
- 150 Pages
Global
From €3544EUR$3,950USD£3,027GBP
- Report
- May 2026
- 156 Pages
Global
From €3544EUR$3,950USD£3,027GBP
- Report
- May 2026
- 152 Pages
Global
From €3544EUR$3,950USD£3,027GBP
- Report
- May 2026
- 157 Pages
Global
From €3544EUR$3,950USD£3,027GBP
- Report
- May 2026
- 156 Pages
Global
From €3544EUR$3,950USD£3,027GBP
- Report
- May 2026
- 150 Pages
Global
From €3544EUR$3,950USD£3,027GBP
- Report
- May 2026
- 153 Pages
Global
From €3544EUR$3,950USD£3,027GBP
- Report
- May 2026
- 148 Pages
Global
From €3544EUR$3,950USD£3,027GBP
- Report
- May 2026
- 146 Pages
Global
From €3544EUR$3,950USD£3,027GBP
- Report
- May 2026
- 146 Pages
Global
From €3544EUR$3,950USD£3,027GBP
- Report
- May 2026
- 149 Pages
Global
From €3544EUR$3,950USD£3,027GBP

Lung cancer is a type of cancer that originates in the lungs. It is the leading cause of cancer-related death worldwide. Oncology is the branch of medicine that deals with the diagnosis, treatment, and prevention of cancer. Lung cancer is one of the most common types of cancer treated by oncologists. Treatment options for lung cancer include surgery, chemotherapy, radiation therapy, and targeted therapy.
The lung cancer market is a rapidly growing segment of the oncology market. It is driven by the increasing prevalence of lung cancer, advances in treatment options, and the increasing availability of targeted therapies. The market is expected to continue to grow in the coming years due to the increasing demand for better treatments and the development of new therapies.
Some companies in the lung cancer market include AstraZeneca, Bristol-Myers Squibb, Eli Lilly, Merck, Novartis, Pfizer, and Roche. Show Less Read more